Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 2/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | QPCT | Q16769 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11187671 | 0.91 | CYP11B1 (0.55) | CYP17A1CYP11B1CYP19A1CYP11B2KMT2A | |
| SCHEMBL9202390 | 0.90 | KIF11 (0.53) | CYP17A1CYP11B1CYP19A1CYP11B2KIF11 | |
| SCHEMBL9202374 | 0.89 | CYP11B1 (0.45) | CYP17A1CYP11B1CYP19A1CYP11B2USP2 | |
| SCHEMBL9198381 | 0.87 | CYP3A4 (0.49) | CYP17A1CYP11B1CYP19A1CYP11B2 | |
| SCHEMBL9202987 | 0.86 | CYP11B1 (0.48) | CYP17A1CYP11B1CYP19A1CYP11B2KMT2A | |
| SCHEMBL9205541 | 0.86 | CYP11B1 (0.47) | CYP17A1CYP11B1CYP19A1CYP11B2KIF11 | |
| SCHEMBL9205856 | 0.85 | CYP11B1 (0.52) | CYP17A1CYP11B1CYP19A1CYP11B2 | |
| SCHEMBL9200907 | 0.85 | CYP19A1 (0.48) | CYP11B1CYP19A1CYP11B2KMT2APOLB | |
| SCHEMBL9199981 | 0.83 | CYP11B1 (0.46) | CYP11B1CYP19A1CYP11B2USP2KMT2A | |
| SCHEMBL11107776 | 0.82 | CYP11B1 (0.65) | CYP17A1CYP11B1CYP19A1CYP11B2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0513149-B1 | PYRIDYLPHENYL NITROGEN HETEROCYCLE-SUBSTITUTED CARBINOLS AND DERIVATIVES THEREOF WITH ANTI-INFLAMMATORY ACTIVITY | DU PONT MERCK PHARMA (US) | 1995-12-13 | — | — | EP | claimed |
| EP-0513149-A1 | PYRIDYLPHENYL NITROGEN HETEROCYCLE-SUBSTITUTED CARBINOLS AND DERIVATIVES THEREOF WITH ANTI-INFLAMMATORY ACTIVITY. | DU PONT MERCK PHARMA (US) | 1992-11-19 | — | — | EP | claimed |
| US-5049570-A | Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity | DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1991-09-17 | — | — | US | claimed |
| WO-1991011445-A1 | PYRIDYLPHENYL NITROGEN HETEROCYCLE-SUBSTITUTED CARBINOLS AND DERIVATIVES THEREOF WITH ANTI-INFLAMMATORY ACTIVITY | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1991-08-08 | — | — | WO | claimed |
| EP-0513149-B1 | PYRIDYLPHENYL NITROGEN HETEROCYCLE-SUBSTITUTED CARBINOLS AND DERIVATIVES THEREOF WITH ANTI-INFLAMMATORY ACTIVITY | DU PONT MERCK PHARMA (US) | 1995-12-13 | — | — | EP | disclosed |
| EP-0513149-A1 | PYRIDYLPHENYL NITROGEN HETEROCYCLE-SUBSTITUTED CARBINOLS AND DERIVATIVES THEREOF WITH ANTI-INFLAMMATORY ACTIVITY. | DU PONT MERCK PHARMA (US) | 1992-11-19 | — | — | EP | disclosed |
| US-5049570-A | Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity | DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1991-09-17 | — | — | US | disclosed |
| WO-1991011445-A1 | PYRIDYLPHENYL NITROGEN HETEROCYCLE-SUBSTITUTED CARBINOLS AND DERIVATIVES THEREOF WITH ANTI-INFLAMMATORY ACTIVITY | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1991-08-08 | — | — | WO | disclosed |